NPCE – neuropace, inc. (US:NASDAQ)
Stock Stats
News
NeuroPace (NASDAQ:NPCE) had its "buy" rating reaffirmed by analysts at UBS Group AG.
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook [Yahoo! Finance]
NeuroPace sees Q4 revenue of about $26.6M [Seeking Alpha]
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Form 4 NeuroPace Inc For: Dec 19 Filed by: LACOB JOSEPH
Form 4 NeuroPace Inc For: Dec 19 Filed by: Kumar Rakhi
Form 4 NeuroPace Inc For: Dec 19 Filed by: Geiger Uri
Form 4 NeuroPace Inc For: Dec 19 Filed by: Fischer Frank M
Form 144 NeuroPace Inc Filed by: Morrell Martha
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.